Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1272 of 21,034 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ONE Clear all

Conditions: Hypersomnia, Idiopathic Hypersomnia, Narcolepsy
Interventions: Clarithromycin followed by placebo, Placebo then Clarithromycin; Drug
Lead sponsor: Lynn Marie Trotti; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Mild Cognitive Impairment
Interventions: Medium Chain Triglyceride Oil, Placebo Oil; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 50 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Neoplasms, Breast
Interventions: lapatinib, carboplatin, trastuzumab, paclitaxel; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2019
U.S. locations: 3
States / cities: La Jolla, California • Indianapolis, Indiana • Greensboro, North Carolina

Conditions: Staphylococcal Infections
Interventions: SA4Ag vaccine low dose, Blood draw, Colonization swab sample, SA4Ag vaccine mid dose, Blood sample, SA4Ag vaccine high dose, Placebo; Biological · Procedure
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 456 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 16
States / cities: Hollywood, Florida • South Miami, Florida • Overland Park, Kansas + 10 more

Conditions: HCV Infection
Interventions: ABT-450, ritonavir, placebo for ABT-450, Placebo for ritonavir; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2009
U.S. locations: 1
States / cities: Waukegan, Illinois

Conditions: Obesity, Weight Gain
Interventions: Black Cherry and Orange Flavored Beverage with added sugar, Strawberry Kiwi &Lemonade Flavored Beverage with added sugar, Black Cherry and Orange Flavored Beverage no added sugar, Strawberry Kiwi & Lemonade Flavored Beverage no added sugar, Water; Dietary Supplement · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 28 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia
Interventions: ASTX727, Dacogen; Drug
Lead sponsor: Astex Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 227 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 39
States / cities: Anniston, Alabama • Phoenix, Arizona • Tucson, Arizona + 32 more

Conditions: Pre-Pectoral Breast Reconstruction Following Mastectomy
Interventions: AlloMend® Acellular Dermal Matrix allograft; Other
Lead sponsor: AlloSource; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Reno, Nevada

Conditions: Obesity, Insulin Resistance
Interventions: Low-Carbohydrate Diet, Low-Fat Diet; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Stanford, California

Conditions: Locally Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Refractory Head and Neck Squamous Cell Carcinoma
Interventions: Losartan, Pembrolizumab, Stereotactic Body Radiation Therapy; Drug · Biological · Radiation
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: Sacramento, California • Aurora, Colorado

Conditions: Multiple Sclerosis
Interventions: Remotely Delivered and Supported Aerobic Walking Exercise Training, Remotely Delivered and Supported Stretching and Toning Exercise Training; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Glioblastoma Multiforme, Glioma of Brain
Interventions: Ribociclib, Everolimus; Drug
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 3
States / cities: Chandler, Arizona • Phoenix, Arizona • Scottsdale, Arizona

Conditions: Influenza
Interventions: GSK Biologicals' influenza vaccine GSK2186877A, GSK Biologicals' Fluarix; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 192 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Malnutrition, Anemia
Interventions: MNP; Dietary Supplement
Lead sponsor: Columbia University; Other
Eligibility: 6 Months to 54 Months
Enrollment: 526 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity & Overweight, Obesity (Disorder)
Interventions: Positive Reinforcement, Positive Reinforcement + Areas for Change; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Metastatic Breast Cancer
Interventions: LY2523355, ixabepilone, pegfilgrastim, filgrastim; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 12
States / cities: Fort Myers, Florida • Pensacola, Florida • Gainesville, Georgia + 9 more

Conditions: Pre Diabetes, Postpartum Disorder
Interventions: Semaglutide Pen Injector [Ozempic], Placebo semaglutide pen injector; Drug
Lead sponsor: Woman's; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Colorectal Cancer Screening
Interventions: Protect Your Colon™; Behavioral
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 45 Years to 75 Years
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Neonatal Hypoglycemia, Neurodevelopmental Disorders
Interventions: Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-4); Diagnostic Test
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Months to 24 Months
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Trauma, Psychological, Motor Vehicle Accident
Interventions: EMDR, PC; Behavioral
Lead sponsor: Trauma Institute & Child Trauma Institute; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Northampton, Massachusetts

Conditions: Poor Quality Sleep
Interventions: Refrain from caffeine techniques, Project REST Platform; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Parkinson Disease, Ketosis
Interventions: Ketone Ester Elite endurance Nutrition Drink, Stool Sample; Dietary Supplement · Other
Lead sponsor: University of Florida; Other
Eligibility: 40 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Mild Cognitive Impairment
Interventions: Voice-activated smart speakers; Other
Lead sponsor: Emory University; Other
Eligibility: 55 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Influenza, Common Cold, Cough, Headache, Fever
Interventions: Pomegranate, Placebo; Dietary Supplement
Lead sponsor: Texas Heart Institute; Other
Eligibility: 21 Years to 49 Years
Enrollment: 461 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: San Diego, California

Search by objective public record fields.

Clarithromycin for the Treatment of Hypersomnia

Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment

Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer.

Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1

Neurobehavioral Plasticity to Regular Sugar-Sweetened Beverage Intake: An fMRI Experiment

Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML

Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction

Weight Loss Diet Study: Low Carb vs Low Fat

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Remote Exercise Effects on Cognitive Processing Speed in Multiple Sclerosis: A Pilot Trial

A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older

Microfinance Institutions as a Platform for Global Health

Examining Valence-based Effects in Self-Monitoring Feedback Messages

A Study of LY2523355 in Participants With Breast Cancer

Treatment to Regress to Normoglycemia in Women with a Recent History of GDM

Impact of Protect Your Colon™ on CRC Screening

Neurodevelopment of Hypoglycemic Neonates

EMDR vs. PC For Motor Vehicle Accident Trauma

Project REST: Club Sports

Effect of Ketone Esters in Parkinson's Disease

Voice Technology-Based Self-Management Intervention

Pomegranate Products for Prevention of Common Cold